How Does Nanotechnology Enhance Checkpoint Inhibitors?
Nanotechnology can significantly enhance the delivery and efficacy of checkpoint inhibitors. Nanoparticles can be engineered to carry these drugs directly to the tumor site, reducing systemic toxicity and increasing the concentration of the drug in the tumor microenvironment. This targeted delivery can lead to more effective tumor reduction and fewer side effects.
